RxSight offers strong growth potential in cataract treatment, with scalable tech, a large market, and attractive valuation.

Explore Frontline's Q1 2025 performance, trading insights linked to Brent oil prices, and valuation analysis. Read more on ...

Enterprise Products Partners is a top pick for MLP investors, offering resilient cash flow, 1.7X coverage, and steady growth ...

Destiny Tech100 fund focuses on private tech ventures like SpaceX, ideal for swing traders seeking high risk, high reward ...

Apple's WWDC is set to run between June 9 and June 13, with the keynote address set for June 9 at 1 p.m. EST.

Tesla's sales are weakening due to a stale product lineup. See here to know how TSLT's volatility and risks make it ...

Badger Meter's inflated valuation might miss reasonable growth expectations. Read more on why water infrastructure, such as ...

Circle’s IPO highlights crypto’s mainstream shift, with USDC driving revenue and new fintech services expanding its reach.

EFT faces income pressure from expected rate cuts, with limited fixed-rate exposure and a below-category yield despite a 9.2% ...

T-Mobile US offers solid growth ahead of consensus, but high capex and tariff risks limit upside. Find out why TMUS stock is ...

Scarce real assets could become the anti-AI play for investors who want to preserve wealth. Read why REITs could present ...

Economic indicators reveal a balanced outlook: strong consumer spending offsets housing negatives. Click for a closer look at ...